BMEA - Biomea Fusion

-

$undefined

N/A

(N/A)

Biomea Fusion NASDAQ:BMEA Biomea Fusion, Inc. operates as a biopharmaceutical company. The Company focuseS on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion serves customers in the United States.

Location: | Website: www.biomeafusion.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

72.01M

Cash

87.95M

Avg Qtr Burn

-28.18M

Short % of Float

51.41%

Insider Ownership

25.02%

Institutional Own.

64.49%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2b

Data readout

BMF-219 (icovamenib) Details
Type 1 diabetes

Big Mover™

Phase 2

Data readout

Phase 2

Initiation

BMF-219 (icovamenib) Details
Solid tumor/s, Colorectal cancer , Pancreatic cancer, Non-small cell lung carcinoma

Phase 1/2

Data readout

BMF-219 (icovamenib) Details
Acute myeloid leukemia, Acute lymphoblastic leukemia

Phase 1

Data readout

Phase 1

Update